Ovarian Cancer | Specialty

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Mirvetuximab Soravtansine Shows Benefit in Folate Receptor Alpha+ Ovarian Cancer

May 4th 2019

The antibody-drug conjugate mirvetuximab soravtansine demonstrated a favorable benefit-risk profile in a prespecified subset of patients with folate receptor alpha–positive ovarian cancer, following a comprehensive analysis of the phase III FORWARD I trial.

Dr. Sabbatini on Promising Therapies in Newly Diagnosed Ovarian Cancer

May 2nd 2019

Paul Sabbatini, MD, deputy physician-in-chief for clinical research, Memorial Sloan Kettering Cancer Center, discusses promising therapies in newly diagnosed ovarian cancer.

Dr. Zamarin on Priming Strategies in Ovarian Cancer

April 30th 2019

Dmitriy Zamarin, MD, PhD, medical oncologist at Memorial Sloan Kettering Cancer Center, discusses priming strategies in ovarian cancer.

Outlook in Treating Patients With Ovarian Cancer

April 29th 2019

Ongoing Research in Ovarian Cancer

April 29th 2019

I/O Combination Strategies in Ovarian Cancer

April 29th 2019

Rationale for Immunotherapy in Ovarian Cancer

April 29th 2019

Ovarian Cancer: Recurrence After PARP Inhibition

April 29th 2019

PARP Inhibitors in Ovarian Cancer: Safety Profile

April 29th 2019

Ovarian Cancer: Predictors of PARP Sensitivity

April 29th 2019

Ovarian Cancer: Selecting Between Available PARPs

April 29th 2019

Approaching Platinum-Sensitive Recurrent Ovarian Cancer

April 29th 2019

PARP + Maintenance Bevacizumab in Ovarian Cancer

April 29th 2019

Detecting Somatic BRCA1/2 Mutations in Ovarian Cancer

April 29th 2019

SOLO-1 and PARP Inhibitors in Ovarian Cancer

April 29th 2019

Current Role of VEGF-Targeted Therapy in Ovarian Cancer

April 29th 2019

Secondary Debulking Surgery in Ovarian Cancer

April 29th 2019

Ovarian Cancer: Neoadjuvant Chemo Vs Primary Debulking

April 29th 2019

Risk-Reducing Surgery in Epithelial Ovarian Cancer

April 29th 2019

Future Directions in Advanced Ovarian Cancer Management

April 29th 2019